Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.34 |
| ▸ | SCN1A | P35498 | 6/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 6/20 | 0.33 |
| ▸ | SCN8A | Q9UQD0 | 6/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SCN1B | Q07699 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27247504 | 1.00 | KDM4C (0.41) | KDM4CSMN1; SMN2MTNR1AMTNR1BSCN1A | |
| SCHEMBL27247764 | 0.87 | KDM4C (0.37) | KDM4CSMN1; SMN2SCN1ASCN5ASCN8A | |
| SCHEMBL30920471 | 0.87 | KDM4C (0.37) | KDM4CSMN1; SMN2SCN1ASCN5ASCN8A | |
| SCHEMBL30946226 | 0.85 | KDM4C (0.37) | KDM4CSMN1; SMN2SCN1ASCN5ASCN8A | |
| SCHEMBL27247607 | 0.85 | KDM4C (0.37) | KDM4CSMN1; SMN2SCN1ASCN5ASCN8A | |
| SCHEMBL30946182 | 0.85 | KDM4C (0.37) | KDM4CSMN1; SMN2SCN1ASCN5ASCN8A | |
| SCHEMBL30946073 | 0.83 | SMN1; SMN2 (0.39) | SMN1; SMN2MTNR1AMTNR1BNPSR1 | |
| SCHEMBL27247799 | 0.83 | LOXL2 (0.38) | KDM4CSCN1ASCN5ASCN8ASCN1B | |
| SCHEMBL31408330 | 0.81 | SMN1; SMN2 (0.40) | SMN1; SMN2MTNR1AMTNR1BNPSR1MAPT | |
| SCHEMBL30946288 | 0.80 | SMN1; SMN2 (0.39) | SMN1; SMN2MTNR1AMTNR1BNPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199546-A1 | INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF | HERCULES CAPITAL, INC., AS AGENT | 2024-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199546-A1 | INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF | SLC6A19, SLC2A9, SLC6A3 | KDM4C 3802/4885SMN1; SMN2 375/4885MTNR1A 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.